Arvinas, Inc.

ARVN

$9.31

-2.92%

N/A-$0.28

Healthcare

Biotechnology

NASDAQ

Active Trading

Arvinas, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to identifying, advancing, and marketing innovative therapies designed to eliminate ...

Insider Transactions of ARVN

Acquisitions (A)

Since Jun 24, 2026

Disposals (D)

Since Jun 24, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jun 24, 2026	Smaldone Alsup Laurie	director	Common Stock	A	15,527	—
Jun 24, 2026	Smaldone Alsup Laurie	director	Stock Option (right to buy)	A	22,714	$8.05
Jun 24, 2026	Norwalk Leslie V	director	Common Stock	A	15,527	—
Jun 24, 2026	Norwalk Leslie V	director	Stock Option (right to buy)	A	22,714	$8.05
Jun 24, 2026	Morrison Briggs	director	Common Stock	A	15,527	—

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

191,205

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Smaldone Alsup Laurie

director • 2 txns

Norwalk Leslie V

director • 2 txns

Morrison Briggs

director • 2 txns

Kennedy Edward Moore Jr.

director • 2 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jun 24, 2026	Smaldone Alsup Laurie	director	Common Stock	A	15,527	—	—
Jun 24, 2026	Smaldone Alsup Laurie	director	Stock Option (right to buy)	A	22,714	$8.05	$182,847.70
Jun 24, 2026	Norwalk Leslie V	director	Common Stock	A	15,527	—	—
Jun 24, 2026	Norwalk Leslie V	director	Stock Option (right to buy)	A	22,714	$8.05	$182,847.70
Jun 24, 2026	Morrison Briggs	director	Common Stock	A	15,527	—	—
Jun 24, 2026	Morrison Briggs	director	Stock Option (right to buy)	A	22,714	$8.05	$182,847.70
Jun 24, 2026	Kennedy Edward Moore Jr.	director	Common Stock	A	15,527	—	—
Jun 24, 2026	Kennedy Edward Moore Jr.	director	Stock Option (right to buy)	A	22,714	$8.05	$182,847.70
Jun 24, 2026	Cunningham Everett	director	Common Stock	A	15,527	—	—
Jun 24, 2026	Cunningham Everett	director	Stock Option (right to buy)	A	22,714	$8.05	$182,847.70

Upstream

Pfizer Inc. (Pfizer CentreOne / PC1)NYSE:PFEContract Manufacturing Organizations (CMOs) — Multiple Unnamed SuppliersContract Research Organizations (CROs) — Multiple Unnamed SuppliersSpecialty Chemical & Reagent SuppliersActive Pharmaceutical Ingredient (API) Intermediate Suppliers

Downstream

Pfizer Inc.NYSE:PFE Novartis AGNYSE:NVS Rigel Pharmaceuticals, Inc.NASDAQ:RIGL Genentech, Inc. (Roche Group)OTC:RHHBYBayer AGETR:BAYN

Proxies

Kymera Therapeutics, Inc.NASDAQ:KYMR Nurix Therapeutics, Inc.NASDAQ:NRIX C4 Therapeutics, Inc.NASDAQ:CCCC

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

No matching stocks found

Arvinas, Inc.

Insider Transactions of ARVN

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of ARVN

Upstream

Downstream

Proxies

Insider Transactions of ARVN

Insider Trading Snapshot

Monthly Insider Activity

Transactions by Title - Shares

Transactions by Title - Counts

Key People: Buy/Sell Activity and Price

Transactions Table

Supply Chain of ARVN

Upstream

Downstream

Proxies